Related Experiment Video
Updated: Jan 19, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
DASH diet decreases CXCL4 plasma concentration in patients diagnosed with coronary atherosclerotic lesions
Magdalena Makarewicz-Wujec1, Jan Henzel2, Mariusz Kruk2
1Department of Clinical Pharmacy and Pharmaceutical Care, Medical University of Warsaw, Poland.
Insights
The DASH diet intervention significantly reduced CXCL4 chemokine levels in patients with coronary artery disease (CAD). This lifestyle change shows promise for managing atherosclerosis progression.
Area of Science:
- Cardiology
- Nutrition Science
- Biochemistry
Background:
- Coronary atherosclerosis is linked to elevated CXCL4 chemokine levels.
- Lifestyle interventions are crucial for managing cardiovascular disease.
- The DASH diet is a recognized dietary pattern for cardiovascular health.
Purpose of the Study:
- To assess the impact of a DASH diet-based lifestyle intervention on plasma CXCL4 concentrations in patients with coronary atherosclerosis.
- To evaluate the effect of dietary intervention on cardiovascular risk markers.
Main Methods:
- A randomized controlled trial (NCT02571803) involving patients with stable coronary artery disease (CAD).
- Interventional group received DASH diet counseling for 6 months; control group had no dietary intervention.
- Body composition, high-sensitivity C-reactive protein, and CXCL4 levels were measured.
Main Results:
- The DASH diet group showed significant reductions in body weight and CXCL4 concentration (p < 0.0001).
- A significant decrease in high-sensitivity C-reactive protein was also observed in the DASH group (p < 0.05).
- No significant changes were noted in the control group.
Conclusions:
- The DASH diet effectively reduces CXCL4 concentration in patients with stable CAD.
- Further research is needed to confirm these findings and assess the impact on atherosclerotic plaque.
- This study highlights the potential of dietary interventions in managing cardiovascular disease markers.
Background And Aims:
Aim of this study involved assessment of the intensive intervention concerning lifestyle based on the DASH diet model on plasma concentration of CXCL4 chemokine among patients with coronary atherosclerosis.
Methods And Results:
The Dietary Intervention to Stop Coronary Atherosclerosis in Computed Tomography Study randomized patients with stable CAD to an interventional group (n = 41), where DASH diet was implemented and the control group (n = 40) without dietary intervention. Dietary counselling was provided to DASH group during all 6 control visits within 6 months of observation. During the study, body weight and body composition were controlled using the bioimpedance method. CXCL4 concentration was determined with the use of ELISA test. Within the DASH group, a significant decrease in body weight, a decrease in high sensitivity C-reactive protein concentration (-0.32 ± 2.8 mg/l; p < 0.05), as well as a decrease in CXCL4 concentration (-3.35 ± 3.4 ng/ml; p < 0.0001) were observed. Occurring changes were not statistically significant within the control group.
Conclusions:
DASH diet lessens CXCL4 concentration among patients with a stable CAD, however, further research is necessary in order to confirm aforementioned results and evaluate the impact on atherosclerotic plaque. THIS TRIAL WAS REGISTERED AT: www.clinicaltrials.gov as NCT02571803.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease I: Introduction
Peripheral Artery Disease III: Interprofessional Care
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents

